Skip to content

Clinical trials

Leukemia, Myeloid, Chronic-Phase trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Not applicable Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20036
20043
20053
20062
20071
20081
20094
20104
20151
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated11
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center6
University of California, San Francisco4
Roswell Park Cancer Institute3
Wake Forest University Health Sciences3
City of Hope Medical Center2
Masonic Cancer Center, University of Minnesota2
OHSU Knight Cancer Institute2
Rex Cancer Center, Raleigh, NC2
Barbara Ann Karmanos Cancer Institute1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase37
Precursor Cell Lymphoblastic Leukemia-Lymphoma32
Leukemia, Myeloid, Accelerated Phase31
Burkitt Lymphoma30
Leukemia, Lymphocytic, Chronic, B-Cell29
Lymphoma, Follicular29
Lymphoma, Large B-Cell, Diffuse29
Lymphoma, Large-Cell, Immunoblastic28
Lymphoma, Mantle-Cell28
Lymphoma, Non-Hodgkin28

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.